Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.
Deepika SureshAshley LiMatthew J MillerKarn WijarnpreechaVincent L ChenPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
In MASLD patients, metabolic hyperferritinaemia was associated with increased mortality and higher incidence of liver-related events, and cirrhosis-promoting alleles but not with iron overload-promoting HFE mutations.